[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

  • Biotechnology
  • Chemicals
  • Food processing
  • Electronics
  • Healthcare
  • Pharmaceuticals


Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

  • Market segmentation
  • Competitive landscape
  • Regulatory policies
  • Latest technology trends
  • Acquisition evaluations
  • Vendors’ analysis, etc.
Publications found: 56,951
Sort by:

2012 US Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 8,560.00

... chemistry and immunodiagnostics markets, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...

April 2012 600 pages

The 2012 France Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

... and immunodiagnostics markets, including: Major issues pertaining to the French clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

April 2012 542 pages

The 2012 Germany Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

... and immunodiagnostics markets, including: Major issues pertaining to the German clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

April 2012 578 pages

2012 Italy Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

... and immunodiagnostics markets, including: Major issues pertaining to the Italian clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

April 2012 561 pages

2012 Japan Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 5,440.00

... and immunodiagnostics markets, including: Major issues pertaining to the Japanese clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

April 2012 559 pages

2012 Spain Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

... and immunodiagnostics markets, including: Major issues pertaining to the Spanish clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, ... ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays ...

April 2012 568 pages

2012 UK Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

... chemistry and immunodiagnostics markets, including: Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...

April 2012 563 pages

2012 European Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 14,799.20

... leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years. The clinical chemistry and immunodiagnostics markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances ...

April 2012 900 pages

2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 22,800.00

... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...

April 2012 1200 pages

2012 Global Agrochemical Companies Product Portfolio Analyses

US$ 1,480.00

For each company, the analyses present: Extensive review of the major product lines. Applications, advantages and weaknesses of leading products. The companies analyzed in the report: Arysta, BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 75 pages.

April 2012 75 pages

2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 585 pages

2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 585 pages

2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 570 pages

2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 5,360.00

This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

April 2012 590 pages

2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 565 pages

2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 4,320.00

This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

April 2012 620 pages

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market

US$ 3,880.00

... accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop ...

April 2012 135 pages

The 2012 Leading Agrochemical Companies Financial Analyses

US$ 1,480.00

Each company’s analysis provides: Sales and operating profit by division, product line, and geographic region. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 85 pages and 65 tables

March 2012 85 pages

The 2012 Leading Agrochemical Companies R&D Expenditures and Major Programs

US$ 1,320.00

For each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 38 pages

March 2012 38 pages

The 2012 Leading Agrochemical Companies Collaborative Arrangements

US$ 1,200.00

... : Major joint ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 56 pages

March 2012 56 pages

The 2012 Leading Agrochemical Companies Business Organizations and Senior Management Profiles

US$ 1,200.00

For each company, the report provides: History of the company's agrochemical business evolution, important to the understanding of the corporate culture, management mentality and strategies. Recent acquisitions, divestitures and significant organizational changes. Current organizational structure. ...

March 2012 85 pages

The 2012 Blood Banking Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks

US$ 760.00

The report identifies the major opportunities for blood banking instruments, consumables, and auxiliary products; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative market penetration strategies for suppliers. Contains 15 pages

March 2012 15 pages

The 2012 Cancer Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks

US$ 680.00

The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative business expansion strategies for suppliers. Contains 15 pages

March 2012 15 pages

The 2012 Top Ten World's Leading Chemical Companies

US$ 11,600.00

... include: To establish comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading chemical companies. To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors. To ...

March 2012 600 pages

The 2012 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers

US$ 22,960.00

... coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing ...

March 2012 650 pages

The 2012 Coagulation Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks

US$ 760.00

The report identifies major opportunities for coagulation instrument and consumable suppliers, proposes “ideal” product models with tentative prices and operating characteristics, and suggests alternative market penetration strategies. Contains 30 pages

March 2012 30 pages

The 2012 French Coagulation Market

US$ 4,320.00

... report presents a comprehensive analysis of the French coagulation market, including: Major issues pertaining to the French coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...

March 2012 405 pages

The 2012 German Coagulation Market

US$ 4,320.00

... report presents a comprehensive analysis of the German coagulation market, including: Major issues pertaining to the German coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...

March 2012 406 pages

The 2012 Italian Coagulation Market

US$ 4,320.00

... report presents a comprehensive analysis of the Italian coagulation market, including: Major issues pertaining to the Italian coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...

March 2012 402 pages

The 2012 Japanese Coagulation Market

US$ 5,200.00

This report presents a comprehensive analysis of the Japanese coagulation market, including: Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

March 2012 402 pages

The 2012 Spanish Coagulation Market

US$ 4,320.00

... report presents a comprehensive analysis of the Spanish coagulation market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...

March 2012 398 pages

The 2012 UK Coagulation Market

US$ 4,320.00

This report presents a comprehensive analysis of the UK coagulation market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...

March 2012 409 pages

The 2012 US Coagulation Market

US$ 6,800.00

This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...

March 2012 424 pages

The 2012 Top Ten World's Leading Diagnostic Imaging Companies

US$ 10,000.00

... establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis ...

March 2012 850 pages

The 2012 Leading Diagnostic Imaging Companies Strategic Directions

US$ 2,000.00

For each company, the report provides insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu ...

March 2012 41 pages

The 2012 Leading Diagnostic Imaging Companies Marketing Tactics

US$ 2,000.00

For each company, the analysis presents: The U.S. and international sales force size in major geographic regions. Selling options, including rental plans, leasing and others. Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System ...

March 2012 50 pages

The 2012 Leading Diagnostic Imaging Companies Comparative Analysis

US$ 680.00

This report ranks the world’s major diagnostic imaging companies according to the following criteria: Sales and market shares in the U.S., Europe, Japan and other geographic regions. Sales by modality. Operating profit and margins. R&D expenditures. The ...

March 2012 5 pages

The 2012 Leading Diagnostic Imaging Companies Collaborations

US$ 1,480.00

For each company, the report analyzes: Major joint venture, distribution, O.E.M., and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, ...

March 2012 82 pages

The 2012 Leading Diagnostic Imaging Companies Financial Analyses

US$ 1,960.00

Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables

March 2012 92 pages

The 2012 Leading Diagnostic Imaging Companies Organizations and Management

US$ 1,480.00

... and strategies. Recent acquisitions, divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...

March 2012 92 pages

The 2012 Leading Diagnostic Imaging Companies R&D Expenditures and Major Programs

US$ 1,480.00

For each company, the report provides: R&D budget, research facilities, and staff. New technologies, systems, and applications in development, including their specifications and anticipated introduction dates. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, ...

March 2012 40 pages

The 2012 Leading Diagnostic Imaging Companies Technological Know-How

US$ 1,480.00

For each company, the report analyzes: Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens ...

March 2012 60 pages

The 2012 Leading Diagnostic Imaging Companies Product Portfolio Analyses

US$ 1,480.00

For each company, the analyses present: Placements and installed base of major systems in the U.S. and abroad, by modality. Review of major product lines. Specifications, features, advantages, weaknesses, introduction dates and prices of current systems. The companies analyzed in the report: Aloka, ...

March 2012 230 pages

The 2012 Leading Diagnostics Imaging Companies Facilities and Employees

US$ 1,480.00

For each company, the analyses present: Location and size of administrative, manufacturing, and R&D facilities in the U.S. and abroad. New plants under construction. U.S. and international work force size and distribution. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...

March 2012 32 pages

The 2012 Top 10 World’s Leading Flavor and Fragrance Companies

US$ 11,360.00

... To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading flavor and fragrance companies. To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a- ...

March 2012 550 pages

The 2012 Leading Flavor and Fragrance Companies Financial Analyses

US$ 1,960.00

For each company, the analysis provides: Sales estimates by product category and geographic region. Five-year sales and operating profit performance. The companies analyzed in the report: Firmenich, Frutarom, Givaudan, T. Hasegawa, IFF, Mane, Robertet, Sensient, Symrise, and Takasago. Contains 65 pages ...

March 2012 65 pages

The 2012 Leading Flavor and Fragrance Companies Major Facilities and Employees

US$ 1,480.00

For each company, the report provides: Production, compounding, creative, and R&D facilities by country. Workforce size. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and Takasago. Contains 52 pages

March 2012 52 pages

The 2012 Leading Flavor and Fragrance Companies Ownership, Business Evolution, Organizations and Senior Management Profiles

US$ 1,480.00

... , the report provides: Background of parent companies, private companies, private owners and shareholder information. History of the company’s flavor and fragrance business evolution, important to the understanding of the corporate culture, management mentality, and strategies. Business evolution milestone ...

March 2012 113 pages

The 2012 Leading Flavor and Fragrance Companies Product Portfolios and Technological Know-How

US$ 1,480.00

For each company, the report analyzes: Major products and services, including fragrances (fine, technical), flavors, aroma chemicals (high-volume standard products, high-volume specialties, low-volume specialties), essential oils, and others. Know-how in chemical technology, biotechnology, aromacology and ...

March 2012 80 pages

The 2012 Leading Flavor and Fragrance Companies Marketing Capabilities

US$ 1,480.00

For each company, the analysis presents: Sales force in the U.S. and other international markets. Major sale office locations. Distribution strategies. Major promotional tactics. The companies analyzed in the report: Firmenich, Givaudan, T. Hasegawa, IFF, Mane, Quest, Robertet, Sensient, Symrise, and ...

March 2012 20 pages

Filters

Search

Categories

3
6
249
2
165
164
52
726
612
487
422
365
289
206
808
227
226
183
47
33
17
17
15
14
10
8
7
5
4
3
2
2
2
1
1
2
5
1,357
40
576
35,170
43
8
15
2
1,289
1,108
237
1,201
134
97
1
69
3
53
631
6
932
21
6
1
253
3,934
324
1
644
585
228
219
202
93
69
35
17
15
812
27
330
85
11
1
1
550
20
108

Publishers

56,951

Regions

16
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
175
194
193
15
104
194
5
174
197
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
192
192
192
192
192
191
191
191
137
137
4
3
2
201
201
198
198
198
197
197
197
197
196
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
191
191
190
188
187
110
107
107
106
106
1,143
201
197
30,291
1,610
1,253
1,251
1,245
1,228
1,218
1,196
401
200

Price

Date

Pages

Offers